Lead Product(s): Mosedipimod
Therapeutic Area: Trauma (Emergency, Injury, Surgery) Product Name: EC-18
Highest Development Status: Preclinical Product Type: Small molecule
Deal Size: $0.1 million Upfront Cash: Undisclosed
Deal Type: Funding January 26, 2021
NASA’s Human Research Program has awarded $150K in grant funding to conduct research on its lead compound EC-18, and how it impacts astronaut health and performance during future long-duration missions beyond low-Earth orbit.